Download
s15010-021-01606-9.pdf 650,18KB
WeightNameValue
1000 Titel
  • CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity
1000 Autor/in
  1. Doehn, Jan-Moritz |
  2. Tabeling, Christoph |
  3. Biesen, Robert |
  4. Saccomanno, Jacopo |
  5. Madlung, Elena |
  6. Pappe, Eva |
  7. Gabriel, Frieder |
  8. Kurth, Florian |
  9. Meisel, Christian |
  10. Corman, Victor M. |
  11. Hanitsch, Leif G. |
  12. Treskatsch, Sascha |
  13. Heim, Kathrin |
  14. Stegemann, Miriam S. |
  15. Ruwwe-Glösenkamp, Christoph |
  16. Müller-Redetzky, Holger C. |
  17. Uhrig, Alexander |
  18. Somasundaram, Rajan |
  19. Spies, Claudia |
  20. von Bernuth, Horst |
  21. Hofmann, Jörg |
  22. Drosten, Christian |
  23. Suttorp, Norbert |
  24. Witzenrath, Martin |
  25. Sander, Leif E. |
  26. Hübner, Ralf-Harto |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-04-06
1000 Erschienen in
1000 Quellenangabe
  • 49(4):757-762
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s15010-021-01606-9 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023546/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Coronavirus disease 2019 (COVID-19) is caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Type I interferons are important in the defense of viral infections. Recently, neutralizing IgG auto-antibodies against type I interferons were found in patients with severe COVID-19 infection. Here, we analyzed expression of CD169/SIGLEC1, a well described downstream molecule in interferon signaling, and found increased monocytic CD169/SIGLEC1 expression levels in patients with mild, acute COVID-19, compared to patients with severe disease. We recommend further clinical studies to evaluate the value of CD169/SIGLEC1 expression in patients with COVID-19 with or without auto-antibodies against type I interferons.
1000 Sacherschließung
lokal SARS-CoV-2/physiology [MeSH]
gnd 1206347392 COVID-19
lokal CD169
lokal Female [MeSH]
lokal COVID-19/immunology [MeSH]
lokal Aged [MeSH]
lokal Hospitalization [MeSH]
lokal Humans [MeSH]
lokal Severity of Illness Index [MeSH]
lokal Longitudinal Studies [MeSH]
lokal Monocytes/immunology [MeSH]
lokal Sialic Acid Binding Ig-like Lectin 1/blood [MeSH]
lokal Retrospective Studies [MeSH]
lokal Type I interferons
lokal Middle Aged [MeSH]
lokal Up-Regulation [MeSH]
lokal COVID-19
lokal COVID-19 / SARS-CoV-2
lokal Brief Report
lokal Male [MeSH]
lokal SARS-CoV-2
lokal SIGLEC1
lokal Sialic Acid Binding Ig-like Lectin 1/biosynthesis [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/RG9laG4sIEphbi1Nb3JpdHo=|https://frl.publisso.de/adhoc/uri/VGFiZWxpbmcsIENocmlzdG9waA==|https://frl.publisso.de/adhoc/uri/Qmllc2VuLCBSb2JlcnQ=|https://frl.publisso.de/adhoc/uri/U2FjY29tYW5ubywgSmFjb3Bv|https://frl.publisso.de/adhoc/uri/TWFkbHVuZywgRWxlbmE=|https://frl.publisso.de/adhoc/uri/UGFwcGUsIEV2YQ==|https://frl.publisso.de/adhoc/uri/R2FicmllbCwgRnJpZWRlcg==|https://frl.publisso.de/adhoc/uri/S3VydGgsIEZsb3JpYW4=|https://frl.publisso.de/adhoc/uri/TWVpc2VsLCBDaHJpc3RpYW4=|https://frl.publisso.de/adhoc/uri/Q29ybWFuLCBWaWN0b3IgTS4=|https://frl.publisso.de/adhoc/uri/SGFuaXRzY2gsIExlaWYgRy4=|https://frl.publisso.de/adhoc/uri/VHJlc2thdHNjaCwgU2FzY2hh|https://frl.publisso.de/adhoc/uri/SGVpbSwgS2F0aHJpbg==|https://frl.publisso.de/adhoc/uri/U3RlZ2VtYW5uLCBNaXJpYW0gUy4=|https://frl.publisso.de/adhoc/uri/UnV3d2UtR2zDtnNlbmthbXAsIENocmlzdG9waA==|https://frl.publisso.de/adhoc/uri/TcO8bGxlci1SZWRldHpreSwgSG9sZ2VyIEMu|https://frl.publisso.de/adhoc/uri/VWhyaWcsIEFsZXhhbmRlcg==|https://frl.publisso.de/adhoc/uri/U29tYXN1bmRhcmFtLCBSYWphbg==|https://frl.publisso.de/adhoc/uri/U3BpZXMsIENsYXVkaWE=|https://frl.publisso.de/adhoc/uri/dm9uIEJlcm51dGgsIEhvcnN0|https://frl.publisso.de/adhoc/uri/SG9mbWFubiwgSsO2cmc=|https://frl.publisso.de/adhoc/uri/RHJvc3RlbiwgQ2hyaXN0aWFu|https://frl.publisso.de/adhoc/uri/U3V0dG9ycCwgTm9yYmVydA==|https://frl.publisso.de/adhoc/uri/V2l0emVucmF0aCwgTWFydGlu|https://frl.publisso.de/adhoc/uri/U2FuZGVyLCBMZWlmIEUu|https://frl.publisso.de/adhoc/uri/SMO8Ym5lciwgUmFsZi1IYXJ0bw==
1000 Hinweis
  • DeepGreen-ID: a7c8b82c4ca84f02becb555a8acc3708 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6444056.rdf
1000 Erstellt am 2023-04-27T11:50:13.524+0200
1000 Erstellt von 322
1000 beschreibt frl:6444056
1000 Zuletzt bearbeitet Fri Oct 20 11:55:28 CEST 2023
1000 Objekt bearb. Fri Oct 20 11:55:28 CEST 2023
1000 Vgl. frl:6444056
1000 Oai Id
  1. oai:frl.publisso.de:frl:6444056 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source